Document is current
Any future updates will be listed below
-
Authors
,
Borghi, Claudio
Omboni, Stefano https://orcid.org/0000-0002-7124-2096
Reggiardo, Giorgio
Bacchelli, Stefano
Esposti, Daniela Degli
Ambrosioni, Ettore
- License Information
-
More Information
Article History
Received: 2 October 2017
Accepted: 4 April 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: Ethics approval of the study protocols was obtained from Ethics Committees of the Coordinating Center at the S. Orsola Hospital in Bologna, Italy and at each participating center. Written informed consent was obtained from each patient before enrollment.
: Competing interest of Prof Claudio Borghi: consultancy for Boheringer Ingelheim, Menarini International, Sanofi, Amgen, Takeda, Novartis, Ely Lilly and Servier. None of the other authors has any conflict of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
